Marina Matilla Martínez

Marina Matilla Martínez graduated with a Microbiology degree at Universitat Autònoma de Barcelona (UAB) in 2022. The same year she started her master’s degree in Advanced Immunology at UB-UAB and graduated in 2023. During her formative years, she had the chance to participate in different research projects that introduced her to the research field. Before joining IrsiCaixa, she completed her master’s thesis in the development of an immunotherapy based in chimeric autoantibody receptors at Hospital Clinic de Barcelona.

In January 2024 she joined the Immunology group (IGG), led by Jorge Carillo, to continue her career as a predoctoral researcher working on the development of a Human Immunodeficiency Virus vaccine.